Tapewire

NYSE · USD

CNMD

CONMED Corp

Export transactions ↓
Tapewire entity
4691
SEC CIK
0000816956
Parsed reports
532

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2025 Filed Mar 17, 2025 20:07 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Tax withholdingCommon Stock 4,316 $58.83 $253,910.28
Disclosure

SEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 2

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,896.635

Read SEC document
March 14, 2025 Filed Mar 17, 2025 20:07 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Exercise / conversionCommon Stock 4,500 $55.42 $249,390.00
Disclosure

SEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 1

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,212.635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:27 UTC
Lalomia BrentVice President QA and RA
Exercise / conversionRSUs (Restricted Stock Units) · Derivative 75 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-009019 · form4.xml · derivative · entry 3

Lalomia Brent · CIK 0001921560 · Vice President QA and RA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75

Underlying: Common Stock · 75 shares

Expires 2032-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:27 UTC
Lalomia BrentVice President QA and RA
Tax withholdingCommon Stock 26 $62.74 $1,631.24
Disclosure

SEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 2

Lalomia Brent · CIK 0001921560 · Vice President QA and RA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,006.057

Read SEC document
March 07, 2025 Filed Mar 11, 2025 18:27 UTC
Lalomia BrentVice President QA and RA
Exercise / conversionCommon Stock 75 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 1

Lalomia Brent · CIK 0001921560 · Vice President QA and RA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,032.057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:11 UTC
Clifford Edward A.VP Global Manufacturing
GrantOptions To Purchase Common Stock · Derivative 26,127 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008298 · form4.xml · derivative · entry 1

Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,127

Underlying: Common Stock · 26,127 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC
Foust Hollie KGeneral Counsel & Corp Sec
GrantOptions To Purchase Common Stock · Derivative 30,738 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008297 · form4.xml · derivative · entry 1

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,738

Underlying: Common Stock · 30,738 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:45 UTC
Ferrell John D.Executive Vice President - HR
GrantOptions To Purchase Common Stock · Derivative 21,516 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008271 · form4.xml · derivative · entry 1

Ferrell John D. · CIK 0001980620 · Executive Vice President - HR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,516

Underlying: Common Stock · 21,516 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:42 UTC
Pelletier Johonna MarieTreasurer and VP, Tax
GrantOptions To Purchase Common Stock · Derivative 9,300 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008270 · form4.xml · derivative · entry 1

Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,300

Underlying: Common Stock · 9,300 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:40 UTC
Lalomia BrentVice President QA and RA
GrantOptions To Purchase Common Stock · Derivative 26,895 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008269 · form4.xml · derivative · entry 1

Lalomia Brent · CIK 0001921560 · Vice President QA and RA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,895

Underlying: Common Stock · 26,895 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:38 UTC
Glaze RichardChief Information Officer
GrantOptions To Purchase Common Stock · Derivative 11,750 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008268 · form4.xml · derivative · entry 1

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

Underlying: Common Stock · 11,750 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:35 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
GrantOptions To Purchase Common Stock · Derivative 26,127 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008266 · form4.xml · derivative · entry 1

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,127

Underlying: Common Stock · 26,127 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed Mar 5, 2025 20:36 UTC
Garner Todd WExecutive Vice President & CFO
GrantOptions To Purchase Common Stock · Derivative 61,475 $0.00 Strike: $58.33 $0.00
Disclosure

SEC source: 0001127602-25-008267 · form4.xml · derivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,475

Underlying: Common Stock · 61,475 shares

Expires 2035-03-03

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 03, 2025 Filed May 15, 2025 13:59 UTC
Epinette StephanVP GM International
GrantRSUs (Restricted Stock Units) · Derivative 17,144 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-014389 · form4.xml · derivative · entry 1

Epinette Stephan · CIK 0001507941 · VP GM International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,144

Underlying: Common Stock · 17,144 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in a four year period with zero (0) shares vesting in 2026; 8,572 shares vesting on 3/3/27; 6,429 shares vesting on 3/3/28 and 2,143 vesting on 3/3/29.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 14:33 UTC
Kaye MarkDirector
GrantRSUs (Restricted Stock Units) · Derivative 152 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006784 · form4.xml · derivative · entry 2

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152

Underlying: Common Stock · 152 shares

Expires 2035-02-24

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 14:33 UTC
Kaye MarkDirector
GrantOptions To Purchase Common Stock · Derivative 1,846 $0.00 Strike: $61.97 $0.00
Disclosure

SEC source: 0001127602-25-006784 · form4.xml · derivative · entry 1

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,846

Underlying: Common Stock · 1,846 shares

Expires 2035-02-24

F1 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 20:01 UTC
Glaze RichardChief Information Officer
SaleCommon Stock 257 $65.35 $16,796.03
Disclosure

SEC source: 0001127602-25-004596 · form4.xml · nonDerivative · entry 1

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
January 27, 2025 Filed Jan 30, 2025 22:48 UTC
Moller Andrew JamesVP Corporate Controller
GrantOptions To Purchase Common Stock · Derivative 5,000 $0.00 Strike: $71.18 $0.00
Disclosure

SEC source: 0001127602-25-002512 · form4.xml · derivative · entry 1

Moller Andrew James · CIK 0002054340 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:19 UTC
Beyer PatPresident & CEO
GrantOptions To Purchase Common Stock · Derivative 86,355 $0.00 Strike: $67.35 $0.00
Disclosure

SEC source: 0001127602-25-000752 · form4.xml · derivative · entry 1

Beyer Pat · CIK 0001627985 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,355

Underlying: Common Stock · 86,355 shares

Expires 2035-01-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
December 31, 2024 Filed Apr 7, 2025 17:07 UTC
Lalomia BrentExecutive VP RA, QA
Other401 (K) Plan 22.993 $68.44 $1,573.64
Disclosure

SEC source: 0001127602-25-011741 · form5.xml · nonDerivative · entry 1

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Indirect · 401 (K) Plan

Disclosed balance after: 93.606

F1 · date: As of December 31, 2024.

Read SEC document
November 20, 2024 Filed Nov 21, 2024 21:13 UTC
Glaze RichardChief Information Officer
Exercise / conversionRSUs (Restricted Stock Units) · Derivative 375 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027803 · form4.xml · derivative · entry 3

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,125

Underlying: Common Stock · 375 shares

Expires 2033-11-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
November 20, 2024 Filed Nov 21, 2024 21:13 UTC
Glaze RichardChief Information Officer
Tax withholdingCommon Stock 118 $70.69 $8,341.42
Disclosure

SEC source: 0001127602-24-027803 · form4.xml · nonDerivative · entry 2

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257

Read SEC document
November 20, 2024 Filed Nov 21, 2024 21:13 UTC
Glaze RichardChief Information Officer
Exercise / conversionCommon Stock 375 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027803 · form4.xml · nonDerivative · entry 1

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 22:02 UTC
Hartman Curt RDirector · President and CEO
Exercise / conversionSARs (Stock Appreciation Rights) · Derivative 30,000 $0.00 Strike: $51.30 $0.00
Disclosure

SEC source: 0001127602-24-026855 · form4.xml · derivative · entry 4

Hartman Curt R · CIK 0001451535 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,300

Underlying: Common Stock · 30,000 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 22:02 UTC
Hartman Curt RDirector · President and CEO
Tax withholdingCommon Stock 24,303 $74.76 $1,816,892.28
Disclosure

SEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 2

Hartman Curt R · CIK 0001451535 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,996

Read SEC document
November 07, 2024 Filed Nov 8, 2024 22:02 UTC
Hartman Curt RDirector · President and CEO
Exercise / conversionCommon Stock 30,000 $51.30 $1,539,000.00
Disclosure

SEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 1

Hartman Curt R · CIK 0001451535 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 23:57 UTC
Foust Hollie KGeneral Counsel & Corp Sec
GrantRSUs (Restricted Stock Units) · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-026616 · form4.xml · derivative · entry 1

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.

F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 19:26 UTC
Garner Todd WExecutive Vice President & CFO
GrantRSUs (Restricted Stock Units) · Derivative 22,727 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-026454 · form4.xml · derivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock · 22,727 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

Read SEC document
September 05, 2024 Filed Sep 9, 2024 14:46 UTC Exercise / conversionSARs (Stock Appreciation Rights) · Derivative 1,000 $0.00 Strike: $39.64 $0.00
Disclosure

SEC source: 0001127602-24-023639 · form4.xml · derivative · entry 3

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2024-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024.

Read SEC document
September 05, 2024 Filed Sep 9, 2024 14:46 UTC Tax withholdingCommon Stock 534 $74.31 $39,681.54
Disclosure

SEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 2

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,346

Read SEC document
September 05, 2024 Filed Sep 9, 2024 14:46 UTC Exercise / conversionCommon Stock 1,000 $39.64 $39,640.00
Disclosure

SEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 19:20 UTC
Clifford Edward A.VP Global Manufacturing
Exercise / conversionRsus (restricted Stock Units) · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-021576 · form4.xml · derivative · entry 3

Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 500 shares

Expires 2033-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 19:20 UTC
Clifford Edward A.VP Global Manufacturing
Tax withholdingCommon Stock 122 $65.34 $7,971.48
Disclosure

SEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 2

Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378

Read SEC document
August 01, 2024 Filed Aug 5, 2024 19:20 UTC
Clifford Edward A.VP Global Manufacturing
Exercise / conversionCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 1

Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2024 Filed Jun 17, 2024 20:22 UTC
Peters Stanley W IIIPresident AS and AET
Exercise / conversionOptions To Purchase Common Stock · Derivative 4,000 $0.00 Strike: $41.93 $0.00
Disclosure

SEC source: 0001127602-24-018832 · form4.xml · derivative · entry 3

Peters Stanley W III · CIK 0001635365 · President AS and AET

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Read SEC document
June 14, 2024 Filed Jun 17, 2024 20:22 UTC
Peters Stanley W IIIPresident AS and AET
SaleCommon Stock 4,000 $71.82 $287,280.00
Disclosure

SEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 2

Peters Stanley W III · CIK 0001635365 · President AS and AET

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63

Read SEC document
June 14, 2024 Filed Jun 17, 2024 20:22 UTC
Peters Stanley W IIIPresident AS and AET
Exercise / conversionCommon Stock 4,000 $41.93 $167,720.00
Disclosure

SEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 1

Peters Stanley W III · CIK 0001635365 · President AS and AET

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:12 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017851 · form4.xml · derivative · entry 4

Workman John L · CIK 0001302537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:12 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017851 · form4.xml · derivative · entry 3

Workman John L · CIK 0001302537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:11 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017850 · form4.xml · derivative · entry 4

BRONSON DAVID M · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:11 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017850 · form4.xml · derivative · entry 3

BRONSON DAVID M · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:08 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017848 · form4.xml · derivative · entry 5

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:08 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017848 · form4.xml · derivative · entry 4

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:09 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017849 · form4.xml · derivative · entry 4

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:09 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017849 · form4.xml · derivative · entry 3

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:06 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017847 · form4.xml · derivative · entry 4

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:06 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017847 · form4.xml · derivative · entry 3

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:05 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017846 · form4.xml · derivative · entry 5

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 01:05 UTC GrantOptions To Purchase Common Stock · Derivative 5,503 $0.00 Strike: $77.18 $0.00
Disclosure

SEC source: 0001127602-24-017846 · form4.xml · derivative · entry 4

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 13:33 UTC GrantRsus (restricted Stock Units) · Derivative 479 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-24-017863 · form4.xml · derivative · entry 4

CONCANNON BRIAN · CIK 0001261784 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479

Underlying: Common Stock · 479 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.